Market Highlights

• Wexford Science & Technology, in partnership with UMB, has officially opened 4MLK, a $180.0 million, 250,000-square-foot (sf) lab and office tower at the University of Maryland BioPark.
• GlaxoSmithKline (GSK) will leave its 635,000-sf Rockville R&D facility by summer 2026, expanding instead at Cambridge Park Drive in Massachusetts.
• BionicM has launched its U.S. subsidiary, BionicM USA, near Washington, D.C., to expand its presence in the world’s largest prosthetics market. The new office will enhance inventory and accelerate sales.

Read the full report